New York, April 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials ...

The topical treatment is the perfect addition to our growing psoriasis portfolio, which includes multiple treatment options that cover the whole spectrum of the disease. We are very happy that we ...

To evaluate the clinical efficacy of iPSc directed to interfere T-cell activation to cure patients with psoriasis. Twenty subjects were enrolled. Each patient was administered iv with syngenic iPS.

A team of dermatologists of the Government Thoothukudi Medical College have made a significant breakthrough in clinical signs and symptoms of psoriasis vulgaris following oral consumption of Neu ...

The topical treatment is the perfect addition to our growing psoriasis portfolio, which includes multiple treatment options that cover the whole spectrum of the disease. We are very happy that we will ...